China SXT Pharmaceuticals
Income Statement

Last updated:

Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. China SXT Pharmaceuticals's past years’ income statements indicate that its last revenue has decreased compared to the previous period by 2% to $1,928,497. The net income raised on -$3,098,532 and profit margin reached -161%. Total operating expenses were $3,069,188.

Profit Margin

China SXT Pharmaceuticals, Inc. (NASDAQ:SXTC): Profit margin
2017 4.88M 1.18M 24.28%
2018 7.01M 1.18M 16.92%
2019 7.01M 1.53M 21.95%
2020 5.16M -10.28M -199.29%
2021 4.77M -2.74M -57.52%
2022 2.60M -5.73M -220.43%
2023 1.97M -5.93M -301%
2024 1.92M -3.09M -160.67%

SXTC Income Statement (2017 – 2024)

2024 2023 2022 2021 2020 2019 2018 2017
Revenue
Revenue
1.92M1.97M2.60M4.77M5.16M7.01M7.01M4.88M
Cost of revenue
1.37M1.54M1.35M1.93M2.45M2.40M3.61M2.56M
Gross profit
553.97K426.27K1.25M2.83M2.70M4.61M3.40M2.31M
Operating exp.
Research and development
00000000
Selling and marketing
433.56K387.45K924.53K1.58M1.58M1.60M512.48K144.36K
Total operating expenses
3.06M6.03M6.44M5.03M4.04M2.84M1.76M709.81K
Operating income
-2.51M-5.60M-5.18M-2.19M4.28M1.76M1.63M1.60M
Other income (expenses), net
-583.31K-327.26K-218.27K-743.79K-9.04M27.14K-3.80K-21.98K
Income before tax
-3.09M-5.93M-5.40M-2.94M-10.38M1.79M1.62M1.58M
Income tax expense
0476.77K328.14K-192.68K-101.72K252.23K440.10K395.04K
Net income
-3.09M-5.93M-5.73M-2.74M-10.28M1.53M1.18M1.18M
Earnings per share
Basic EPS
-3.57-22.23-137.92-95.48-832.08149.67115.480
Diluted EPS
-3.57-22.23-137.92-95.48-832.08149.67115.480
Data sourceData sourceData sourceData sourceData sourceData source